Search results
What was behind the Chancellor’s statement and are tax rises more likely?
PA Media: UK News via Yahoo Canada News· 1 day agoThe warnings of very difficult decisions ahead suggest the forthcoming Budget will clearly be...
School strikes unlikely in England after 5.5% pay offer
BBC News· 1 day agoThe offer is being funded by an additional £1.2bn from the government. The National Education Union...
Jeremy Hunt: Chancellor should stop ‘trash-talking’ UK economy
PA Media: UK News via Yahoo Canada News· 1 day ago“Paul Johnson of the IFS (Institute for Fiscal Studies) says the state of public finances were...
Winter fuel payments scrapped for millions of pensioners
BBC News· 1 day agoAround 10 million pensioners in England and Wales will lose their winter fuel payments under new...
Golan Heights strike: Deadly football pitch attack was under two miles from base targeted by...
SKY News· 1 day agoBased on the launch site location provided by the Israeli military, the rocket would have travelled...
Analysis forecasts more heart attacks and strokes under the new cardiovascular risk calculator tool
Medical Xpress· 1 day agoA recently unveiled cardiovascular disease risk calculator that measures a patient's risk for heart attack and stroke is better calibrated and more precise than its previous ...
Macular Degeneration: Daily Supplement May Slow Progression
Healthline· 1 day agoDry age-related macular degeneration is an eye disorder that can lead to blindness. A formulation of...
Alzheimer's blood test catches 90 per cent of early dementia cases, study finds
CTV News· 1 day agoPrimary care doctors had even less success, with only a 61 per cent accuracy rate, according to the ...
Biovaxys Signs Binding Letter of Intent to Develop DPX™-Based Vaccines for Life Threatening Food...
CNW· 1 day agoAPVI is founded by Asha Parekh, CEO of Frontline Medical ...
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
Digital Journal· 1 day agoThe proposed transaction will create a Nasdaq-traded, biotechnology company with product candidates in advanced stages of clinical development and focused on advancing Kadimastem's ...